RPLP2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.313400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.312600E-01
Normal-vs-Stage2
8.406800E-01
Normal-vs-Stage3
6.878200E-01
Normal-vs-Stage4
8.899600E-01
Stage1-vs-Stage2
8.499200E-01
Stage1-vs-Stage3
8.074800E-01
Stage1-vs-Stage4
9.015800E-01
Stage2-vs-Stage3
6.261800E-01
Stage2-vs-Stage4
9.977800E-01
Stage3-vs-Stage4
6.248600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.039400E-01
Normal-vs-AfricanAmerican
6.537400E-01
Normal-vs-Asian
8.778000E-01
Caucasian-vs-AfricanAmerican
3.363400E-01
Caucasian-vs-Asian
6.280200E-01
AfricanAmerican-vs-Asian
3.613800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.542000E-01
Normal-vs-Female
6.187200E-01
Male-vs-Female
1.723050E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.203800E-01
Normal-vs-Age(41-60Yrs)
6.062600E-01
Normal-vs-Age(61-80Yrs)
8.820200E-01
Normal-vs-Age(81-100Yrs)
6.340200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.725800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.716400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.431380E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.664800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.978500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.592220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.863400E-01
Normal-vs-Daily Drinker
9.213000E-01
Normal-vs-Weekly Drinker
8.465200E-01
Normal-vs-Occasional Drinker
8.355800E-01
Normal-vs-Social Drinker
6.369200E-01
Non Drinker-vs-Daily Drinker
5.702800E-01
Non Drinker-vs-Weekly Drinker
5.767200E-01
Non Drinker-vs-Occasional Drinker
8.322400E-01
Non Drinker-vs-Social Drinker
3.941800E-01
Daily Drinker-vs-Weekly Drinker
7.455200E-01
Daily Drinker-vs-Occasional Drinker
5.087400E-01
Daily Drinker-vs-Social Drinker
2.299000E-01
Weekly Drinker-vs-Occasional Drinker
5.294600E-01
Weekly Drinker-vs-Social Drinker
3.682400E-01
Occasional Drinker-vs-Social Drinker
5.822600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.980600E-01
Normal-vs-Grade 2
7.194800E-01
Normal-vs-Grade 3
6.720000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.770000E-01
Grade 1-vs-Grade 3
7.840800E-01
Grade 1-vs-Grade 4
6.980600E-01
Grade 2-vs-Grade 3
6.629200E-01
Grade 2-vs-Grade 4
7.194800E-01
Grade 3-vs-Grade 4
6.720000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.111400E-01
Normal-vs-NonDiabetic
8.245000E-01
Diabetic-vs-NonDiabetic
2.824600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.767200E-01
Normal-vs-NoPancreatitis
8.563400E-01
Pancreatitis-vs-NoPancreatitis
3.426400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.830800E-01
Normal-vs-N1
8.039600E-01
N0-vs-N1
3.372600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.372600E-01
Normal-vs-TP53-NonMutant
9.391600E-01
TP53-Mutant-vs-TP53-NonMutant
5.982000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
